Dr Sridevi Gutta

Dr. Sridevi Gutta is a Gynaecologic oncologist, Gynaecologist & Obstetrician in the Departments of Gynaecologic oncology and Gynaecology & obstetrics. she worked as a Senior Resident in MNJ Cancer Hospital, Hyderabad and as an Asst. Professor at Akash Medical College, Bangalore. She is among the panel of doctors for Durgabai Deshmukh Hospital and Research Centre, Hyderabad. She is an accomplished and astute professional with over 10 years of versatile exposure and demonstrated hands on experience in all aspects of obstetrics and gynecology and gynaec-oncology. Having significant exposure in obstetrics and gynaecology and gynaec-oncology management, she is capable of managing all kinds of obstetrics and high risk pregnancies and infertility cases including emergencies, surgical managements, forceps/vacuum deliveries and MTP’s, medical and surgical management of ectopic pregnancies. As a part of her practice, she conducts health camps, cancer screening programs and counselling programs on a regular basis. She manages terminally ill cancer patients by effective pain management and palliative care. Her research focus is mainly gynecologic cancers and their treatment. Her areas of interest include high risk pregnancies, gynecologic oncology, fertility-sparing surgery, cervical cancer, uterine/ endometrial cancer, ovarian cancer, vaginal cancer, vulvar cancer, developmental therapeutics, advanced-stage gynecologic cancer and gestational trophoblastic disease. A Spectrum of Challenges According to Dr. Sridevi, seeing a patient with cervical cancer is “heartbreaking” because it is an almost entirely preventable disease. If a woman undergoes screening by having Pap smear done, cervical cancer’s prevalence becomes incredibly rare. Furthermore, increased use of the HPV vaccine and appropriate cervical screening would eliminate nearly all cervical cancers. Cervical cancer can be prevented and to ensure this everyone must have access to screening and prevention. Ovarian cancer presents yet another challenge as there is no reliable way to screen or detect it in the early stage. However, the Brightside is more aggressive & innovative surgeries and new ways of delivering chemotherapy, which can help women with ovarian cancer to live longer. She strongly recommends all women to get evaluated by a physician trained in gynaeconcology in time as the prognosis and outcome immensely depend on timely diagnosis and prompt surgical and other primary form of treatment.